Quantcast

Latest Heart failure Stories

2014-04-29 12:29:21

Randy Shepherd, Kept Alive for 10 Months by the SynCardia Total Artificial Heart Powered by the Freedom Portable Driver, Walked the April 26, 2014 Long-Distance Course Honoring Pat Tillman TUCSON, Ariz., April 29, 2014 /PRNewswire/ -- Randy Shepherd's 4.2-mile walk in Pat's Run April 26, 2014, in the Phoenix area was more than a test of his endurance. It was part of his training for the most crucial event of his life--a heart transplant....

2014-04-28 12:30:28

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/b9jbpq/global) has announced the addition of the "Global Hypertension Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking...

2014-04-28 10:11:32

Large sections of the genome that were once referred to as “junk” DNA have been linked to human heart failure, according to research from Washington University School of Medicine in St. Louis. So-called junk DNA was long thought to have no important role in heredity or disease because it doesn’t code for proteins. But emerging research in recent years has revealed that many of these sections of the genome produce RNA molecules that, despite not being proteins, still have important...

2014-04-25 09:44:40

Fibroblasts, cells long thought to be boring and irrelevant, could offer an alternative to heart transplants for patients with heart disease. Researcher Dr Milena Furtado, and her team from the Australian Regenerative Medicine Institute (ARMI) at Monash University, found the heart cell fibroblast is a close relative to a cardiomyocyte, the cell responsible for a healthy beating heart. In research published today in Circulation Research, Dr Furtado has found that cardiac fibroblasts are...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-14 12:31:23

Considerable Opportunity Exists for Therapies Offering Reductions in Mortality and Hospitalization Rates, According to Findings from Decision Resources Group BURLINGTON, Mass., April 14, 2014 /PRNewswire/ -- Decision Resources Group finds that Servier's ivabradine (procoralan) is set to become the clinical gold-standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's sound clinical...

2014-04-10 09:55:23

Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitaliization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and...

2014-04-08 12:31:04

Becker's Hospital Review Focuses on Cutting-Edge Healthcare Information for Hospital and Healthcare Leaders TUCSON, Ariz., April 8, 2014 /PRNewswire/ -- More than two-thirds, 35, of SynCardia's 52 Certified Centers in the United States are on the "100 Great Hospitals in America" list published by Becker's Hospital Review. http://photos.prnewswire.com/prnvar/20140408/LA00151 "When more than a third of America's top 100 hospitals have the SynCardia temporary Total Artificial Heart it...

2014-04-07 23:23:27

Transparency Market Research Report Added "Global Cardiac Assist Devices Market Research Report Analysis, Trends and Forecast 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/cardiac-assist-devices.html Albany, New York USA (PRWEB) April 07, 2014 Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. Cardiac...

2014-04-08 00:22:26

DEERFIELD, Ill., April 8, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064 the jury found in favor of the plaintiffs and awarded $1.475 million in compensatory damages. The allocation of liability was 75% Takeda and 25% Eli Lilly. The jury also awarded $6 billion in punitive damages from Takeda and $3 billion from co-defendant, Eli Lilly. The trial began...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related